Peter Michael Moyle (Peter M Moyle, Peter Moyle)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Bioconjugate chemistry

Molecules (Basel, Switzerland)

Vaccines

Drug delivery and translational research

University of Queensland

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Queensland Jan 01 2019

Australia

Senior Lecturer :: School of Pharmacy

University of Queensland - Dec 31 2018

Australia

Lecturer :: School of Pharmacy

University of Queensland

Australia

NHMRC Postdoctoral Fellow :: School of Chemistry and Molecular Biosciences

University of Queensland

Australia

Postdoctoral Research Fellow :: School of Chemistry and Molecular Biosciences

Kenmore Day and Night Pharmacy

Australia

Pharmacist in Charge :: Pharmacist

Acacia Pharmacy

Australia

Pharmacist :: Pharmacist

University of Queensland

Australia

Casual Tutor :: School of Pharmacy

Education History

University of Queensland - Nov 06 2006

Australia

PHD :: School of Pharmacy

Publications

Tania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, Patrick Marchant, Amanda J Cork, Gayathiri Elangovan, Anna Henningham, Jason N Cole, Biswa Choudhury, Peter Michael Moyle, Istvan Toth, Michael R Batzloff, Michael F Good, Paresh Agarwal, Neeraj Kapoor, Victor Nizet, Guido Silvestri, Mark J Walker
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model. Vaccines 12 (4) (2024)
Tania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, Patrick Marchant, Amanda J Cork, Gayathiri Elangovan, Anna Henningham, Jason N Cole, Biswa Choudhury, Peter Michael Moyle, Istvan Toth, Michael R Batzloff, Michael F Good, Paresh Agarwal, Neeraj Kapoor, Victor Nizet, Guido Silvestri, Mark J Walker
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model. Vaccines 12 (4) (2024)
Frazer Sinclair, Anjuman A Begum, Charles C Dai, Istvan Toth, Peter Michael Moyle
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing. Drug delivery and translational research (2023)
Niwanthi Rajapakse, Haru Nomura, Melanie Wu, Jiangning Song, Andrew Hung, Shirley Tran, Hang Ta, Fahima Akther, Yuao Wu, Matt D Johansen, Keng Chew, Vinod Kumar, Trent M Woodruff, Richard J Clark, Johannes Koehbach, Bruno Lomonte, Carlos Rosado, Merlin Thomas, Marion Boudes, Cyril Reboul, Lachlan D Rash, Linda Gallo, Sumia Essid, Dominika Elmlund, Stefan Miemczyk, Nicole Hansbro, Bernadette Saunders, Warwick Britton, Peter D Sly, Ayaho Yamamoto, Julián Fernández, Peter Michael Moyle, Kirsty Short, Philip Hansbro, Sanjaya Kuruppu, Ian Smith
Development of a novel angiotensin converting enzyme 2 stimulator with broad implications in SARS-CoV2 and type 1 diabetes. Research square (2023)
Sitah Alharthi, Amirali Popat, Zyta Maria Ziora, Peter Michael Moyle
Sortase A Inhibitor Protein Nanoparticle Formulations Demonstrate Antibacterial Synergy When Combined with Antimicrobial Peptides. Molecules (Basel, Switzerland) 28 (5) (2023)
Sitah Alharthi, Amirali Popat, Zyta Maria Ziora, Peter Michael Moyle
Sortase A Inhibitor Protein Nanoparticle Formulations Demonstrate Antibacterial Synergy When Combined with Antimicrobial Peptides. Molecules (Basel, Switzerland) 28 (5) (2023)
Sitah Alharthi, Amirali Popat, Zyta Maria Ziora, Peter Michael Moyle
Sortase A Inhibitor Protein Nanoparticle Formulations Demonstrate Antibacterial Synergy When Combined with Antimicrobial Peptides. Molecules (Basel, Switzerland) 28 (5) (2023)
Frazer Sinclair, Anjuman A Begum, Charles C Dai, Istvan Toth, Peter Michael Moyle
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing. Drug delivery and translational research (2023)
Sitah Alharthi, Zyta Maria Ziora, Taskeen Janjua, Amirali Popat, Peter Michael Moyle
Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides. Pharmaceutics 14 (5) (2022)
Seyed Ebrahim Alavi, Peter J Cabot, Aun Raza, Peter Michael Moyle
Developing GLP-1 Conjugated Self-Assembling Nanofibers Using Copper-Catalyzed Alkyne-Azide Cycloaddition and Evaluation of Their Biological Activity. Bioconjugate chemistry 32 (4) (2021)
Zhenghui Xu, Peter Michael Moyle
A Self-Adjuvanting Vaccine Platform: Optimization of Site-Specific Sortase A Mediated Conjugation of Toll-Like Receptor 2 Ligands onto the Carboxyl or Amino terminus of Recombinant Protein Antigens. ChemPlusChem 85 (1) (2021)
Zhenghui Xu, Tania Rivera-Hernandez, Peter Michael Moyle
Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination Vaccine. ACS infectious diseases 6 (7) (2020)
Faheem Maqbool, James R Falconer, Peter Michael Moyle
Supercritical fluid assembly of albendazole liposomes targeting gastrin-releasing peptide receptor overexpressing tumors. Nanomedicine (London, England) (2020)
Seyed Ebrahim Alavi, Peter John Cabot, Gee Yi Yap, Peter Michael Moyle
Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using Copper-Catalyzed Alkyne-Azide Cycloaddition. Bioconjugate chemistry 31 (7) (2020)
Sławomir Andrzejewski, Peter Michael Moyle, Brett W Stringer, Jason C Steel, Christopher J Layton
Neutralisation of adeno-associated virus transduction by human vitreous humour. Gene therapy 28 (5) (2020)
Seyed Ebrahim Alavi, Peter J Cabot, Peter Michael Moyle
Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency. Molecular pharmaceutics 16 (6) (2019)
Jia Ying Cheang, Peter Michael Moyle
Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes. ChemMedChem 13 (7) (2018)
Zhenghui Xu, Peter Michael Moyle
Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands. Bioconjugate chemistry 29 (3) (2017)

Peter Michael Moyle.css-eqlu8i{font-size:small;padding-left:4px;} (Peter M Moyle, Peter Moyle)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Michael Moyle (Peter M Moyle, Peter Moyle)